
Friday, June 14, 2019 6:54:11 PM
Recent MRKR News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/04/2025 10:08:04 PM
- Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 02/25/2025 12:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 10:02:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 10:20:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 10:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 10:18:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 10:17:32 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/14/2025 10:09:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/04/2025 09:05:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/04/2025 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 09:05:26 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/17/2025 09:13:02 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/13/2025 09:05:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2025 10:09:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 09:01:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 09:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:30:19 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/23/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 01:21:17 PM
- Marker Therapeutics Announces $16.1 Million Private Placement • GlobeNewswire Inc. • 12/19/2024 01:06:43 PM
- Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma • GlobeNewswire Inc. • 12/19/2024 01:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:10:42 PM
FEATURED 1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting • Mar 11, 2025 8:30 AM
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • ELAB • Mar 10, 2025 9:05 AM
North Bay Resources Announces Assays up to 5.69% Copper, 1 Opt. Silver, and 0.22% Vanadium at Copper Island Project, British Columbia • NBRI • Mar 10, 2025 9:00 AM
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare • AVAI • Mar 10, 2025 8:00 AM
Veri Medtech (VRHI) Network Grows To 400 Physicians • VRHI • Mar 10, 2025 7:32 AM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM